HLA

Papers
(The median citation count of HLA is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
A registry‐based population study of the HLA in Québec, Canada102
Issue Information59
Three novel HLA‐DQA1 alleles identified in Brazilian individuals by next‐generation sequencing47
38
Characterization of the novel HLA‐DQA1*03:11 allele by next‐generation sequencing26
Characterization of two new HLA alleles: HLA‐A*02:982 and HLA‐C*04:44120
Characterization of the novel HLA‐A*36:12 allele by sequencing‐based typing20
Full genomic sequence of the HLA‐A*02:01:01:241 allele identified by next‐generation sequencing17
Characterization of three novel HLA alleles: HLA‐B*44:481:02, HLA‐DQB1*03:338N, and HLA‐DQB1*06:46716
The novel HLA‐DRB1*16:71 allele characterised by two different sequencing‐based typing techniques14
Identification of three novel HLA class I alleles: HLA‐B*15:640, ‐B*18:01:01:71 and ‐C*05:27513
Characterization of the novel HLA‐A*24:585 allele by sequencing‐based typing13
Novel Synonymous HLA‐B*35:01:80 Allele Identified by Next‐Generation Sequencing12
The Novel HLADPB1*1498:01 Allele, Identified by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual12
A novel allele, HLA‐C*15:227, identified when typing COVID‐19 patients11
Characterisation of the Novel HLA‐DQB1*06:469 Allele by Next‐Generation Sequencing11
Characterization of the novel HLA‐DRB1 allele, HLA‐DRB1*04:328 in a Chinese individual10
Discovery of the novel HLA‐B*52:49N allele in a Chinese individual10
Issue Information9
Issue Information9
Identification of HLA‐DPA1*01:03:01:57 and HLA‐DPA1*02:01:01:29 from a case–control study of atopic dermatitis9
Issue Information8
The novel HLA‐DRB1*14:07:03 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual8
Characterization of the novel HLA‐B*13:02:01:18 allele in a North Indian individual8
Issue Information8
The novel KIR2DL4*00108 allele identified by sequencing‐based typing in a Chinese Han individual8
Characterization of the novel HLA‐C*04:438 allele by next generation sequencing8
Epitope characterization of a monoclonal antibody that selectively recognizes KIR2DL1 allotypes8
Detection of a novel allele, HLA‐DPA1*01:58, originating from a recombination within exon 2 of the DPA1 gene7
Identification of a novel HLA‐C*07 allele, HLA‐C*07:943, in a Spanish individual7
A novel HLA allele, HLA‐A*32:74, detected by sequencing in a Chinese individual7
The novel HLA‐A*31:191 allele was identified in a Chinese platelet donor7
Characterization of the novel HLA‐B*57:02:01:03 allele by sequencing‐based typing7
Identification of the novel HLA‐DQB1*03:454 allele using next‐generation sequencing7
Identification of the novel allele, HLA‐B*44:256, in an individual from West Bengal in Eastern India7
Identification of the novel HLA‐C*03:03:01:52N allele, a splice‐site variant at the boundary of intron1 and exon27
A novel HLA‐B allele, HLA‐B*50:04:02, detected in a Russian hematopoietic stem cell donor7
Discovery of the novel HLA‐C*06:195 allele in a Singaporean unrelated hematopoietic stem cell donor6
Detection of an HLA‐C*08 variant, HLA‐C*08:01:31, in a Chinese individual6
Identification of the novel HLA‐DPA1*01:149 allele by next‐generation sequencing6
Characterization of the novel HLA‐DPB1*04:02:01:40 allele by Oxford nanopore sequencing (ONT) technology6
Recognition of the HLA‐A*24:353 allele and its associated HLA haplotype in a Taiwanese patient6
Issue Information6
Characterization of the novel HLA‐DPA1*01:159 allele by sequencing‐based typing6
Characterization of the novel HLA‐B*07:482 allele using next‐generation sequencing methods6
Recognition of the HLA‐B*15:86 allele and its associated HLA haplotype in a Taiwanese individual6
HLA‐EPI: A new EPIsode in exploring donor/recipient epitopic compatibilities6
The novel HLA‐A*02:672Q allele, identified by Sanger dideoxy nucleotide sequencing in a Taiwanese individual6
Nomenclature for factors of the HLA system, update July, August and September 20236
Characterization of the novel HLA‐B*51:394Q allele by sequencing‐based typing5
Identification of the novel HLA‐A*24:585:02 allele using next‐generation sequencing5
Characterization of the novel HLA‐C*06:312 allele by two next‐generation sequencing methods5
The novel HLA‐A*02:405 allele characterized by sequencing‐based typing5
Characterization of three novel HLA class I alleles, HLA‐A*31:01:02:56, HLA‐B*35:588 and HLA‐B*57:1535
Characterization of the novel HLA‐B*07:491 allele by next generation sequencing5
The new HLA‐DQA1*03:50Q allele discovered by next‐generation sequencing in a Korean family5
Characterization of the novel HLA‐B*51:01:01:83 allele in three individuals from North India5
Detection of the HLA‐A*11:32:01 allele in a Taiwanese bone marrow donor5
The novel HLA‐B*13:01:23 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual5
Characterization of the novel HLA‐DPA1*02:122 allele by sequencing‐based typing5
Discovery of the novel HLA‐A*01:01:01:112 allele in a Greek volunteer bone marrow donor5
Genomic sequence of the HLA‐B*08:01:71, HLA‐B*51:382, and HLA‐B*55:01:30 alleles5
Characterization of the novel HLA‐B*52:01:01:18 allele in a West Indian individual5
Next‐generation sequencing identifies two novel HLA‐DPB1 alleles: HLA‐DPB1*1069:01 and DPB1*1072:015
Characterization of the novel HLA‐DQB1*03:516 allele by next‐generation sequencing5
Identification of the novel HLA‐B*40:06:01:18 allele in a North Indian individual5
Characterization of the novel HLA‐C*01:263 allele by sequencing‐based typing5
The novel HLAC*07:1058 allele characterised by two different sequencing‐based typing techniques4
Recognition of the HLA‐A*11:85 allele in a Taiwanese bone marrow donor4
Characterisation of the novel HLA‐DPB1*1618:01 allele by sequencing‐based typing4
Characterization of the novel HLA‐A*29:02:38 allele by sequencing‐based typing4
Recognition of the HLA‐A*02:570:01 allele in Taiwanese individuals4
The novel HLA‐DPB1*1550:01 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual4
Identification of the novel HLA‐DQA1*05:75 allele by next‐generation sequencing in a Korean cord blood donor4
Recognition of the HLA‐A*02:840 allele, a variant of A*02:07:01:01, in a Taiwanese individual4
Identification of the novel HLA‐A*29:171 allele by next‐generation sequencing4
The novel HLADQB1*03:02:01:14 allele was possibly generated by a recombination event4
Discovery of the novel HLA‐DRB1*09:31:02 allele in a College of American Pathologists HLA Survey specimen4
A novel HLA‐DQA1*01 allele, HLA‐DQA1*01:99, identified by next‐generation sequencing4
Issue Information4
HLA‐DQA1*03:03:01:16Q, a novel allele with an acceptor splice site mutation4
Detection of the novel HLA‐B*55:123 allele in a Taiwanese bone marrow donor4
Author Index4
Issue Information4
Identification of the novel HLA‐DRB1*15:184 allele by next‐generation sequencing4
HLA‐A*26:35, a variant of HLA‐A*26, detected in a Taiwanese individual4
4
Issue Information4
Identification of a novel HLA‐A allele, HLA‐A*31:97, by sequence‐based typing4
4
Identification of the novel HLA‐B allele, HLA‐B*44:532 by next‐generation sequencing4
Identification of the novel HLA‐C*12:349 allele in a potential hematopoietic stem cell donor4
Diversity of NKG2C genotypes in a European population: Conserved and recombinant haplotypes in the coding, promoter, and 3′‐untranslated regions4
The novel HLA‐C*06:02:105 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual4
Characterization of the novel HLA‐A*03:425 allele by two next‐generation sequencing methods4
Discovery of the novel HLA‐C*07:1052 allele, a variant of HLA‐C*07:02:01:01, in a Greek individual4
Issue Information4
Four novel HLA alleles: HLA‐DPA1*01:03:01:68, ‐DPA1*01:03:01:71, ‐DQA1*02:01:01:06, and ‐DQB1*06:03:01:194
Discovery of the novel HLA‐C*08:03:05 allele in a Taiwanese individual4
HLA allele and haplotype frequencies in Kazakhstani Russians and their relationship with other populations4
The novel alleles, HLA‐G*01:04:09 and HLA‐DPB1*04:01:01:136, detected in a hematopoietic cell donor4
The novel HLA‐C*08:273 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual4
A novel HLA‐DQB1*03 variant allele, HLA‐DQB1*03:01:01:64, identified by next‐generation sequencing4
The novel HLA‐A*24:49:02 and HLA‐DQB1*06:428 alleles identified in Indian bone marrow donors4
Characterization of the novel HLA‐B*15:598 allele identified in a Korean individual by sequence‐based typing4
Full genomic sequence of the HLA‐DRB3*02:22:01 allele by single molecule real‐time sequencing technology4
Issue Information4
Identification of the novel HLA‐DRB3*02:02:19 allele4
Identification of the novel HLA‐B*51:01:01:78 allele and confirmation of extended sequence of B*18:01:264
Genomic sequence of the HLAB*15:01:02 and HLAC*08:72:01 alleles identified in Gujarati individuals4
Donor HLA genotyping of ex vivo expanded urine cells from kidney transplant recipients4
Full genomic sequence of the HLA‐C*15:02:03 allele identified by next generation sequencing4
4
Discovery of the novel HLA‐C*01:179 allele in a southern Chinese patient4
Three HLA‐DQB1 alleles, DQB1*03:432, DQB1*03:454 and DQB1*03:465 were identified in Chinese individuals4
HLA‐DQA1*05:115, the first DQA1 allele described with an alanine at position 59 of alpha‐1 domain4
Post‐transplant de novo anti‐HLA donor specific antibodies may contribute to poor graft function after haploidentical haematopoietic stem cell transplantation4
Issue Information4
A single nucleotide substitution in exon 5 produced the novel allele, HLA‐B*40:01:834
Buryats from Republic of Buryatia and Irkutsk Region, Russia4
Characterization of the novel HLA‐B*44:324:02 allele by sequencing‐based typing4
Identification of the novel HLA‐B*46:83 allele by sequencing‐based typing in a Chinese individual4
Characterization of a novel HLA‐C allele, HLA‐C*05:278N4
Detection of an HLA‐C*01 variant, HLA‐C*01:212, in a Chinese individual4
Characterization of the novel HLA‐A*32:172 allele by next generation sequencing4
Characterization of the novel HLA‐A*01:405 allele by two next generation sequencing methods4
Identification of the novel HLA‐C*01:65:02 allele by next‐generation sequencing4
Validation of new HLA‐J alleles assigned by next generation sequencing4
Characterization of the novel HLADQB1*02:200 allele by sequencing‐based typing4
Identification of six new HLA‐C variants with nucleotide changes in non‐coding regions4
Discovery of the novel HLA‐DRB1*07:136 allele in a Taiwanese patient4
Identification of the novel HLA‐B*55:107 allele in a Chinese bone marrow donor4
Characterization of the novel HLA‐A*31:11:02 allele by next generation sequencing4
Contents4
A novel null HLA‐B allele, B*40:510N, due to a single nucleotide deletion in exon 24
Characterization of the novel HLA‐DQA1*01:81 allele by sequencing‐based typing4
Detection of the HLA‐B*15:01:74 allele, an HLA‐B*15 variant discovered in a Japanese individual4
Characterization of the novel HLA‐C*01:214 allele by sequencing‐based typing4
Characterization of the novel HLA‐A*01:406 allele by two next generation sequencing methods4
Characterization of the novel HLA‐A*33 allele, HLA‐A*33:03:55 in a Chinese individual4
Genomic full‐length sequence of the HLA‐B*40:86 allele identified in a Chinese individual4
Discovery of the novel HLA‐A*11:417N allele in a Taiwanese individual4
The novel HLA‐A*32 allele, HLA‐A*32:01:56, identified by next generation sequencing4
Engineered HCMV‐infected APCs enable the identification of new immunodominant HLA‐restricted epitopes of anti‐HCMV T‐cell immunity4
Genomic full‐length confirmatory sequence of HLA‐DQB1*04:59N allele in three Colombian individuals3
HLA alleles associated to susceptibility to gliptin‐associated bullous pemphigoid in Italian patients3
Characterisation of Novel HLADQA1 and ‐DQB1 Alleles in a Spanish Bone Marrow Donor: DQA1*05:05:23 and DQB1*03:5623
The novel HLA‐C*04:441:01:02 allele was identified in three unrelated bone marrow donors3
Characterisation of a novel HLA‐A*33:33:02 allele in two members of a North Indian family3
The HLA‐C*14:152 Allele Was Identified Using a Next‐Generation Sequencing Method3
Characterization of the novel HLA‐B*35:502 allele3
The novel HLA‐A*24:618 allele identified in Ecuadorian individual from New York City3
Identification of HLA‐B*13:01:01:12 by Next Generation Sequencing in Indian Population3
Two novel HLA class I alleles, HLA‐C*04:493 and ‐A*26:01:78, identified using next‐generation sequencing3
Report from the extended HLA‐DPA1 ~ promoter ~ HLA‐DPB1 haplotype of the 18th international HLA and immunogenetics workshop3
Characterisation of the Novel HLA‐B*40:587 Allele by Sequencing‐Based Typing3
Genome‐wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA‐A*033
The Novel HLA‐E Allele, HLA‐E*01:151, Identified in a Chinese Individual3
Identification of the novel HLAB*51:367 allele in a cord blood donor by next‐generation sequencing3
Using single antigen specificity magnetic beads for the isolation of specific antibodies against HLA antigens3
The novel non‐classical HLA‐F*01:12 allele identified in a Brazilian individual3
Next Generation Sequencing Identifies Two Novel HLA‐B Alleles, HLA‐B*37:113 and HLA‐B*41:02:123
The Novel HLA‐B*40:02:39 Allele Characterised by Two Different Sequencing‐Based Typing Techniques3
Two novel HLADQB1 alleles identified by next generation sequencing3
3
3
The New HLA‐B*44:384 Allele Characterised by Two Different Sequencing‐Based Typing Techniques3
Cumulative mean fluorescent intensities of HLA specific antibodies predict antibody mediated rejections after kidney transplantation3
Identification of Two Novel HLA Class II Alleles, DPB1*1626:01Q and DRB1*11:337, by Next‐Generation Sequencing3
Characterization of two novel HLA alleles: HLA‐A*26:01:01:53 and DRB1*01:1413
The HLA‐B*37:107 Allele Identified in a Volunteer Donor for Haematopoietic Stem Cell Transplant3
A new HLA‐B allele, HLA‐B*07:4223
Characterisation of the novel HLA‐C*15:274 allele using short and long‐read sequencing technologies3
The deadly face of felid killer cells: The cytotoxic proteins and their genes3
Two novel HLA‐DQB1 alleles identified in potential hematopoietic stem cell donors: DQB1*03:01:50 and ‐DQB1*03:4533
Identification of the novel HLA‐C*08:291 allele by next‐generation sequencing3
Identification of the Novel HLADRB3*02:185 Allele by Next‐Generation Sequencing in a Post‐Transplant Renal Patient3
Identification of the novel HLADPA1*01:106 allele by next‐generation sequencing in a Korean cord blood donor3
Discovery of the novel HLA‐B*35:611 allele, a variant of the HLA‐B*35:64:01 allele3
Clinical Applicability of 2‐Field High‐Resolution and Extended HLA‐Allele Typing in Deceased Donor Kidney Allocation3
Characterization of the novel HLA‐B*58:01:01:19 allele by next‐generation sequencing3
The novel HLA‐A*02:1135 allele identified in a Chinese individual from New York City3
Identification of the Novel HLA‐DPA1*02:143 Allele by Next‐Generation Sequencing3
Identification of a novel HLA‐C allele, HLA‐C*03:618N3
Identification of novel HLA‐C*17:78 allele in North Indian individuals3
Characterization of the Novel HLA‐C*07:01:126 Allele by Sequencing‐Based Typing3
Characterization of the novel HLA‐C*07:977 allele by two next‐generation sequencing methods3
Six New Variants of HLADPA1*01:03 Identified by Next‐Generation Sequencing3
Identification of the Novel HLA‐DQB1*03:01:01:69 Allele in a Candidate Bone Marrow Donor by Next Generation Sequencing3
Identification of the novel HLA‐B*50:01:17 allele by polymerase chain reaction sequence‐based typing3
Characterisation of the novel HLA‐DQA1*01:02:24 allele by sequencing‐based typing3
The novel HLA‐A*26:01:81 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual3
Identification of the new allele HLA‐C*04:01:01:186 in a Greek individual using next generation sequencing3
The HLA‐B*51:377N Allele Identified in a Volunteer Donor for Haematopoietic Stem Cell Transplant3
Sequence‐based typing identification of the novel allele HLA‐B*40:4823
High‐throughput genotyping of HLA‐G, HLA‐F, MICA, and MICB and analysis of frequency distributions in healthy blood donors from 3
Identification of the novel allele HLA‐A*02:1144 in a Chinese platelet donor3
Distributions of MICA and MICB Alleles Typed by Amplicon‐Based Next‐Generation Sequencing in South Koreans3
Identification of the Novel HLA‐A*02:1098 Allele by Sanger Dideoxy Nucleotide Sequencing in a Chinese Individual3
Genomic full‐length sequence of the novel HLA‐B*40:540N allele3
Characterization of the novel HLA‐DQA1*01:03:11 allele by sequencing‐based typing3
Identification of the Novel HLA‐B*38:122 Allele Using Next‐Generation Sequencing in a Turkish Individual3
A retrospective analysis to evaluate if KIR B haplotype donors associate with a reduced risk of relapse in patients with haematological malignancies following haploidentical transplantation at the Blo3
Characterization of the novel HLA‐DRB1*04:04:20 allele by sequencing‐based typing3
Discovery of the HLA‐C*08:99 allele in a Chinese individual3
Characterisation of two new HLA‐A alleles: HLA‐A*01:454 and HLA‐A*31:2293
Characterization of KIR+NK cell subsets with a monoclonal antibody selectively recognizing KIR2DL1 and blocking the specific interaction with HLA‐C3
Foreword from the Local Organizing Committee3
Improving HLA typing imputation accuracy and eplet identification with local next‐generation sequencing training data3
Expression of specific HLA class II alleles is associated with an increased risk for active tuberculosis and a distinct gene expression profile3
The novel HLA‐A*02:1009 allele was identified in four unrelated bone marrow donors3
Refining cPRA calculation to improve HLA compatibility assessment in organ transplantation: A detailed picture of the Paris waiting list3
The Full‐Length Genomic Sequence of the HLA‐B*40:186:02 Allele3
Identification of three novel HLA class II alleles: HLA‐DQA1*02:28, ‐DQA1*05:01:08:02 and ‐DQB1*03:02:01:133
Characterisation of the novel HLA‐A*31:01:53 allele by next generation sequencing in a Chinese individual3
Influence of HLA‐G 3′ Untranslated Region Haplotypes and SNP +3422 Gene Variants as Host Genetic Factors on the Outcomes of SARSCoV‐2 Infection During Acute an3
Identification of the novel HLA‐DQA1*01:01:01:10 allele in an individual from Orissa, India3
Characterisation of the novel HLA‐A*24:630 allele by sequencing‐based typing3
Identification of three new HLA‐A intronic variants by next‐generation sequencing3
Identification of the novel HLA‐B*46:95N allele in a Chinese blood donor3
The novel non‐classical HLA‐G*01:55 identified in a Chinese individual3
Identification of the Novel HLA‐A*03:01:01:122 Allele in a Chinese Individual Using PacBio HiFi Sequencing3
Next generation sequencing reveals a novel HLA‐C allele, HLA‐C*16:2013
The novel HLA allele, HLA‐DQB1*02:211, identified in a Brazilian bone marrow donor3
Characterisation of the Novel HLA‐DRB1*16:79 Allele Using Short‐ and Long‐Read Sequencing Technologies3
MR1 encompasses at least six allele groups with coding region alterations3
The HLA‐A*31:217 Allele Identified in a Volunteer Donor for Haematopoietic Stem Cell Transplant3
Identification of the novel HLA‐DQA1*01:82 allele by next‐generation sequencing3
3
Issue Information3
Characterisation of the Novel HLA‐DRB5*02:02:05 Allele by Sequencing‐Based Typing3
The novel HLA‐B*35:501 allele, identified by sanger dideoxy nucleotide sequencing in a Chinese individual3
Population designations in biomedical research: Limitations and perspectives3
Identification of the novel HLA‐A*30:221 allele by next‐generation sequencing3
Associations of classical HLA alleles with sleep behaviours3
The New HLA‐DRB1*07:159 Allele Characterised by Two Different Sequencing‐Based Typing Techniques3
Presence of antibodies against HLA class I and class II molecules in children before and after allo‐HSCT. Alloantibodies before and after HSCT3
Detection of two HLA‐B*35 variants: HLA‐B*35:01:01:39 and ‐B*35:03:01:323
Characterisation of Eight Novel HLA‐A Alleles From Bone Marrow Volunteers3
Foreword from the President of the European Federation for Immunogenetics3
3
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARSCoV‐2 in Exposed Individuals From Emilia Romagna Region and COVID‐19 Severity3
Detection of an HLA‐A*02 variant, HLA‐A*02:99:01, in a Taiwanese individual3
Identification of the Novel HLA‐DPA1*01:214 Allele in a Brazilian Bone Marrow Donor3
Characterization of the novel HLA‐DPB1*1584:01 allele, identified by next‐generation sequencing3
Characterisation of two novel HLA‐B alleles, B*13:194 and B*15:694 in individuals from Lithuania3
Identification of the novel HLA‐DRB1*03:01:32 in an Italian patient3
Identification of the novel HLA‐DPA1*02:82 allele in a Punjabi individual3
Seven new HLA alleles characterised by next‐generation sequencing3
The HLA‐B*40:523 Allele Identified in a Volunteer Donor for Haematopoietic Stem Cell Transplant3
0.098935127258301